Lori Clarke

690 total citations
9 papers, 456 citations indexed

About

Lori Clarke is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Lori Clarke has authored 9 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Lori Clarke's work include Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and Cancer Research and Treatments (2 papers). Lori Clarke is often cited by papers focused on Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and Cancer Research and Treatments (2 papers). Lori Clarke collaborates with scholars based in United States, Slovakia and Australia. Lori Clarke's co-authors include Suzanne Forry‐Schaudies, Gary P. Sims, Kim Rosenthal, Carl Hay, Raghothama Chaerkady, Taylor S. Cohen, Tomas Mustelin, Nanette Mittereder, Sonja Hess and David L. Ennist and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lori Clarke

9 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lori Clarke United States	8	262	168	159	144	60	9	456
Mikko Savontaus Finland	11	190 0.7×	211 1.3×	86 0.5×	79 0.5×	62 1.0×	20	496
Ursula R. Sorg Germany	13	254 1.0×	108 0.6×	177 1.1×	186 1.3×	54 0.9×	26	580
L. Stievano Italy	11	179 0.7×	75 0.4×	234 1.5×	107 0.7×	66 1.1×	16	493
Korina G. Veenstra United States	6	139 0.5×	54 0.3×	216 1.4×	317 2.2×	37 0.6×	8	484
Thomas B. Okarma United States	12	234 0.9×	187 1.1×	91 0.6×	139 1.0×	33 0.6×	21	527
Hui‐Chien Kuo United States	11	205 0.8×	255 1.5×	228 1.4×	62 0.4×	43 0.7×	18	549
Tomoyuki Ogura Japan	11	120 0.5×	96 0.6×	157 1.0×	330 2.3×	16 0.3×	28	558
Jun Diao Canada	17	192 0.7×	87 0.5×	305 1.9×	742 5.2×	41 0.7×	20	951
Zane C. Neal United States	12	162 0.6×	62 0.4×	167 1.1×	255 1.8×	17 0.3×	17	445
Casey A. Carlos United States	8	200 0.8×	102 0.6×	159 1.0×	268 1.9×	15 0.3×	12	502

Countries citing papers authored by Lori Clarke

Since Specialization

Citations

This map shows the geographic impact of Lori Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Clarke more than expected).

Fields of papers citing papers by Lori Clarke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Clarke. The network helps show where Lori Clarke may publish in the future.

Co-authorship network of co-authors of Lori Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Clarke. A scholar is included among the top collaborators of Lori Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Clarke. Lori Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Gilbreth, Ryan, Cui Chen, Erin Sult, et al.. (2020). 112 Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy. SHILAP Revista de lepidopterología. A69.2–A70. 1 indexed citations

Oganesyan, Vaheh, Peng Li, Jared S. Bee, et al.. (2018). Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody. Journal of Biological Chemistry. 293(22). 8439–8448. 55 indexed citations

Zhou, Yebin, Ling–Ling An, Raghothama Chaerkady, et al.. (2018). Evidence for a direct link between PAD4-mediated citrullination and the oxidative burst in human neutrophils. Scientific Reports. 8(1). 15228–15228. 76 indexed citations

Habiel, David M., Ana Camelo, Milena S. Espíndola, et al.. (2017). Divergent roles for Clusterin in Lung Injury and Repair. Scientific Reports. 7(1). 15444–15444. 28 indexed citations

Chen, Bo, Allison L. Miller, Marlon C. Rebelatto, et al.. (2015). S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro and In Vivo. PLoS ONE. 10(2). e0115828–e0115828. 95 indexed citations

Sachsenmeier, Kris F., Carl Hay, Lori Clarke, et al.. (2012). Development of a Novel Ectonucleotidase Assay Suitable for High-Throughput Screening. SLAS DISCOVERY. 17(7). 993–998. 15 indexed citations

Ryan, Patricia C., John Jakubczak, David A. Stewart, et al.. (2004). Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer. Cancer Gene Therapy. 11(8). 555–569. 36 indexed citations

Bristol, J. Andrew, Mingzhu Zhu, Hong Ji, et al.. (2003). In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF. Molecular Therapy. 7(6). 755–764. 67 indexed citations

Jakubczak, John, Patricia C. Ryan, M Gorziglia, et al.. (2003). An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.. PubMed. 63(7). 1490–9. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact